Objectives. Children with acute bloody diarrhea are at risk of being infected with Shiga toxin-producing Escherichia coli (STEC) and of progression to hemolytic uremic syndrome. Our objective was to identify clinical and laboratory factors associated with STEC infection in children who present with acute bloody diarrhea.
Children with acute bloody diarrhea are at risk of having a Shiga toxin-producing Escherichia coli (STEC) infection and, by extension, hemolytic uremic syndrome (HUS) [1] [2] [3] . Depending on the region and the season, up to 15% of children who present to an emergency facility with acute bloody diarrhea are infected with STEC, and 15% to 20% of these children will develop HUS in the 2 weeks after the onset of diarrhea [3] [4] [5] [6] . Most children with stringently defined (urinalysis-independent) HUS experience anuria, and the risk of chronic sequelae is related directly to the occurrence and duration of anuria [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . In many centers, children with bloody diarrhea or proven STEC infection are not admitted until HUS develops [21] , so the opportunity to mitigate disease progression is missed [22, 23] .
Vigorous volume expansion early in the course of the illness and lesser degrees of hemoconcentration when HUS is diagnosed are associated with improved outcomes, especially avoidance of anuria and death [22] [23] [24] [25] [26] [27] . Given this evidence, an approach to management is to hospitalize all patients with acute bloody diarrhea for intravenous volume expansion pending stool culture results [23] . However, such an "admit-all" approach would overhospitalize children who are at no risk of renal injury because they are infected with a pathogen that does not cause HUS. Risk stratification of children who present with acute bloody diarrhea could lead to more cost-effective practices by assessing the likelihood of a patient having an STEC infection and, by extension, the risk of developing HUS. However, most analyses of children with acute bloody diarrhea in emergency settings are nested within larger studies of children with any cause of diarrhea [28] .
D-Dimer concentrations have been found to be abnormal in children with STEC infection compared with those in healthy controls, which prompts us to consider their use as a screening test with which to identify those with a STEC infection. D-Dimers, which are formed as intravascular fibrin clots undergo degradation, reflect intravascular thrombin accretion; small-vessel thrombi are hallmarks of HUS, and their levels are also elevated before the onset of profound vascular injury. However, it is unknown if circulating D-dimer concentrations are elevated in people with another infectious cause of bloody diarrhea.
Here, we report the results of a pilot prospective cohort study designed to identify clinical and laboratory risk factors in children who present with acute bloody diarrhea and to test the specific hypothesis that plasma D-dimer concentrations, which are known to be abnormal in people with a STEC infection [5] , can predict STEC infection and, therefore, risk for HUS.
PATIENTS AND METHODS
This prospective cohort study included consecutive children younger than 18 years with bloody diarrhea who presented to the emergency department (ED) or were admitted directly to the gastroenterology, hepatology, and nutrition inpatient service at St. Louis Children's Hospital between August 1, 2013, and August 1, 2014. We excluded patients whose bloody diarrhea was of greater than 2 weeks' duration or who were known to have a chronic gastrointestinal illness (eg, inflammatory bowel disease), who had an obvious noninfectious source of bloody stool (eg, hemorrhoid or fissure), who were wards of the state, and/or whose families had English language barriers. Research assistants or trained staff enrolled patients in the ED or on the inpatient ward 24 hours/ day. Missed eligible patients were identified by chart review using International Statistical Classification of Diseases (ICD) codes. The study was approved by the Washington University institutional review board. Informed consent was obtained from each patient's parents or guardians, and assent was obtained from patients aged 7 years or older.
Interventions
A standardized history and physical examination form that detailed each patient's course of illness was completed by trained staff. D-Dimer concentrations were measured up to 2 times, at enrollment and during the next clinically indicated blood draw. Supernatants of plasma anticoagulated with citrate were frozen at −80°C. D-Dimer testing was performed using a latex-enhanced microparticle turbidimetric assay on an STA-Compact system (Diagnostica Stago, Asnieres sur Seine, France) and are reported in fibrinogen equivalent units (FEU) (upper limit of normal, 0.5 μg/mL). Results of the participants' stool cultures and daily laboratory tests and clinical outcomes were obtained from the electronic medical records. Per St. Louis Children's Hospital protocol, all patients with acute bloody diarrhea are admitted for intravenous volume expansion and daily blood tests (to obtain hemoglobin, electrolyte, and creatinine concentrations) until STEC infection has been excluded or, if a patient is infected with STEC, until hematologic stabilization is achieved [1] . Stool cultures in our institution are routinely plated on receipt in the laboratory, at all hours and on all days, on blood agar containing ampicillin, Hektoen enteric agar, MacConkey agar, sorbitol-MacConkey agar (SMAC) agar, Campylobacter blood agar, Yersinia selective agar, and Gram-negative (GN) broth to recover enteric pathogens (all media are from Remel, Lenexa, Kansas). Sorbitolnonfermenting colonies are sought on the SMAC agar and, when present, are tested with an E coli O157 latex agglutination test and autoagglutination control (Remel) to identify E coli O157. The Premier enzyme-linked immunosorbent assay is performed on overnight GN broth culture to identify the presence of Shiga toxins 1 and 2 (Meridian Bioscience, Inc, Cincinnati, Ohio). All E coli O157 isolates and positive GN broths (if enzyme-linked immunosorbent assay results were positive and SMAC agar culture results were negative), are forwarded to the Missouri State Public Health Laboratory (Jefferson City, Missouri) for STEC isolation and characterization, including serotyping. All clinical decisions that involve study participants were made at the discretion of each patient's physician/provider(s) independent of study participation.
Definitions
Bloody diarrhea was defined as at least 1 grossly bloody loose stool in the 24 hours before presentation. HUS was defined as a hematocrit level of <30%, a platelet count of <150 × 10 9 /µL, and a creatinine concentration above the upper limit of normal for age [29] . The first day of illness was considered to be the first day of diarrhea.
Statistical Analysis
We report continuous data as medians with the interquartile range (IQR) and categorical data as proportions with the 95% confidence interval (CI). Categorical variable comparisons for the STEC and non-STEC groups and for the culture-positive and culture-negative groups are presented as differences in proportions with the 95% CI. The significance of differences between medians for continuous variables among groups was determined by the 2-tailed Mann-Whitney U test. We used SPSS for Windows 22 (IBM, Armonk, New York) for all analyses.
Sample Size
On the basis of previous ED and microbiological data, we estimated that we typically treat ~100 patients with bloody diarrhea per year, mostly during summer months. We also estimated that of these 100 patients, 10 to 15 would have an STEC infection and 3 would develop HUS.
Outcomes
Our primary outcome was stool culture results that were positive for STEC.
RESULTS
Of 135 eligible children, 7 refused consent, and 20 were missed, most of whom were hospitalized for <24 hours and were infected with Shigella sonnei as a result of a local community outbreak. No missed patient was infected with STEC or developed HUS. The median age of the 108 enrollees was 3 years (IQR, 1-7 years), and 56% were male. The median durations of illness and of bloody diarrhea before presentation were 3 days (IQR, 2-5 days) and 1 day (IQR, 1-1 day), respectively. Ten (9%) patients tested positive for STEC (E coli O157:H7, n = 8; E coli O111, n = 1; E coli O103, n = 1), and 2 developed HUS, both of whom were infected with E coli O157:H7; neither of these patients required dialysis. The median interval between admission to the ED or the inpatient service and the receipt of a specimen for culture in the laboratory was 2.3 hours (IQR, 1.5-3.2 hours). The median time to resumptive positive report after receipt was 24.5 hours (IQR, 20-37 hours). No other patient developed HUS. Stools from 34 (32%) patients contained a non-STEC bacterial pathogen (S. sonnei, n = 26; Salmonella species, n = 6; Campylobacter jejuni, n = 1; Clostridium difficile, n = 1). No culture contained more than 1 bacterial enteric pathogen. For 2 of these 108 subjects, new-onset ulcerative colitis was found during their hospitalization, and their stool culture results were negative, as expected. Compared to children with another identifiable (usually infectious) cause of bloody diarrhea, children infected with STEC were older, were more likely to have abdominal tenderness, and had higher hemoglobin and creatinine concentrations at presentation. D-Dimer concentrations did not significantly differ between the groups (Table 1) .
We further analyzed differences in clinical and laboratory characteristics of children with stool culture results that were positive for any organism and those with Clinical dehydration score [28] .
negative stool culture results ( Table 2) . As a group, patients whose stools contained any bacterial pathogen were older, had more stools in the 24 hours before presentation, more frequently reported fever and incontinence, and were more likely to have been in contact with people with bloody and nonbloody diarrhea. D-Dimer concentrations differentiated patients with bloody diarrhea caused by any bacterial pathogen from those with a negative stool culture result (positive likelihood ratio, 2.47 [95% CI, 1.6-3.82]) ( Figure 1 and Table 3 ).
DISCUSSION
To our knowledge, this is the first study to have focused exclusively on a cohort of children who presented to a pediatric ED with acute bloody diarrhea. As expected, many of them were infected with a bacterial enteric pathogen. Although some clinical and laboratory features increased the likelihood of an STEC infection, no characteristic was categorically distinguishing.
Chandler et al [5] found D-dimer concentrations in patients with E coli O157:H7 infection to be elevated significantly over those in healthy controls, but they did not test patients infected with any other bacterial pathogen. We, too, documented concentrations of circulating D-dimers well above normal in STEC-infected patients; however, these abnormal D-dimer concentrations did not have sufficient sensitivity or specificity to distinguish STEC infections from other bacterial causes of bloody diarrhea. The elevated D-dimer concentration in those with any bacterial etiology indicates that some form of vascular prothrombotic activation resulting in fibrin deposition occurred in these patients, which suggests that the vascular system might play some role in host response to enteric infections and should Clinical Dehydration Score [28] .
be the subject of future investigations. Elevated D-dimer concentrations cannot be explained simply as a host response to a breach in the intestinal vasculature, because the children with bloody diarrhea without an identifiable microbial cause had considerably lower circulating D-dimer concentrations. Holtz et al [1] proposed characteristics of patients with an STEC infection, including nonbloody diarrhea that becomes bloody after 1 to 3 days, no fever at the point of presentation, a tender abdomen, more than 5 stools in the previous 24 hours, and pain worsening during defecation. We found that abdominal tenderness on physical examination differed significantly between children infected with STEC and those with another bacterial pathogen or a negative stool culture result. Interesting to note is that although they resembled data from an ED study in Seattle, the duration of illness, defecation frequency, and report of pain during defecation also were not differentiating. Nonbloody diarrhea that subsequently became bloody, number of stools in the previous 24 hours, and history of abdominal pain were not differentiating.
Klein et al [28] identified travel outside the United States, history of blood in stool, greater than 10 episodes of diarrhea in previous 24 hours, abdominal pain, and abdominal tenderness as characteristics of enteric bacterial infection. History of antibiotic use in the previous 30 days, duration of symptoms greater than 10 days, and vomiting were more characteristic of nonbacterial infections. In our study, children with positive stool culture results (all bacterial pathogens) were older, had a greater number of stools in the previous 24 hours, had a history of fever and incontinence, and were more likely to have been in contact with people with diarrhea. Ten percent of children in the positiveculture-result group and 19% of those in the negative-cultureresult group reported recent previous antibiotic use. Unlike in the comparison of the STEC and non-STEC groups, we did not find that abdominal pain or tenderness distinguished between the culture-positive and culture-negative groups; however, D-dimer concentrations were significantly higher in the group of those who tested positive for any bacterial enteric pathogen. Although none of the clinical or laboratory risk factors seem to have enough sensitivity in isolation to differentiate patients with an STEC infection from those with another cause of bloody diarrhea at presentation, we were able to profile these children partially. D-Dimer concentrations distinguished patients with a bacterial etiology from those for whom no bacterial etiology was identified with stool culture. These data can be used to build larger studies that integrate clinical and laboratory variables to derive clinical decision models and pathways in patients with bloody diarrhea. Creating such models will be important particularly in making judicious and cost-effective use of emerging and promising technologies such as multiplex polymerase chain reaction analysis of stool [30] .
New rapid molecular diagnostic tests such as multiplex polymerase chain reaction will likely improve detection of STEC infection in the ED in the near future. However, the indiscriminate use of these tests, particularly in patients with a low pretest probability of STEC infection, might result in false-positive results and high costs. Decision models for the use of molecular testing, including clinical factors and simple laboratory tests such as measuring a patient's D-dimer concentration, could be studied to increase the yield and decrease the cost of these emerging technologies. Although applying exclusion criteria for culture analysis to children with acute bloody diarrhea might be impractical, tests such as the measurement of D-dimer concentrations might be useful in cases of nonbloody diarrhea, in which a bacterial pathogen is much less likely to be the culprit. However, until these data are validated, we believe that all children who present to a pediatric ED with acute painful bloody diarrhea should be assumed to have an STEC infection and therefore be at risk for HUS.
We note several limitations to this study. First, our relatively small sample size did not enable us to construct complex decision models or study subgroups according to time of presentation (as clinical and laboratory profiles change over the course of an infection). However, all our patients presented within 1 day of the identification of blood in the stool. Second, in view of geographic, interinstitutional, and seasonal differences in the etiologies and incidences of bloody diarrhea, our data might not be universally applicable. Nonetheless, to our knowledge, this is the largest study to date to have focused exclusively on ED presentation of acute bloody diarrhea in children and, as such, can be used to inform future studies.
CONCLUSION
In this study, D-dimer concentrations did not have sufficient sensitivity or specificity to distinguish children with an STEC infection from those with any other cause of bloody diarrhea at the time of presentation. However, D-dimer concentrations might be able to distinguish children with bloody diarrhea from an infectious etiology and those with any other cause of bloody diarrhea. We found older age and abdominal tenderness to be statistically significant in distinguishing children with an STEC infection; however, it would be difficult to clinically dismiss the risk of STEC infection in younger children or those without abdominal tenderness. At this time, no reliable clinical or laboratory predictors accurately identify children with an STEC infection and who therefore are at risk of HUS at the time of presentation. Therefore, we strongly believe that any child with bloody diarrhea should be considered to have an emergent condition, such as an STEC infection, that requires timely diagnosis and intervention.
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